Rapid COVID-19
Antigen Tests

Health Canada Authorized Testing Device

Health Canada Authorized

Authorized by Health Canada for point-of-care testing.

Results in 15 Minutes

Easy-to-use test with instructional videos and easy-to-follow diagrams.

As Low As $8.98/test

Available in 5-Packs and 25-Packs, starting as low as $8.98/test.

DISCLAIMER

Before Rapid Testing kits can be purchased, customers must review all of the training material listed under the product description (instructional video, procedure card, product manual).

It is your responsibility to ensure that you have the appropriate knowledge, skills and judgement to perform the test. Rapid antigen tests are intended for use by trained laboratory personnel or health care professionals.

Rapid antigen testing devices should only be used for screening purposes. Nucleic acid-based testing, also called molecular testing or PCR, is the gold standard to diagnose active COVID-19 infection in patients with symptoms. For more information about self-testing and antigen testing devices, please visit the Health Canada website here.

IMPACT OF THE OMICRON VARIANT

Impact of the Omicron variant of SARS-CoV-2 on BTNX’s Rapid Response® COVID-19 Antigen Rapid Test Device

Statement from device manufacturer.

HOW IT WORKS

1. Review Demonstration Video

This demonstration video provides step-by-step instruction for collecting nasal specimens and performing the rapid antigen test.

The Canadian Shield - BTNX Inc. Rapid Response COVID-19 Rapid Antigen Test Kit

2. Review Procedure Card & Product Manual

Review the written instructions and diagrams for collecting test specimens and performing the rapid antigen test.

3. Agree to the Terms & Conditions

Confirm your understanding of the rapid test training documents as well as The Canadian Shield's Ecommerce Order Agreement.

BTNX Rapid Response® Instructional Video

This instructional video is for 5-Packs and 25-Packs of the BTNX Rapid Response® COVID-19 Antigen Test Kits.

Procedure Card

Antigen Testing Devices Information & Resources

Information, regulations, and guidance around the use of rapid antigen testing devices in Canada is frequently changing. While The Canadian Shield website is updated often, we recommend referring to the Health Canada website for the most up to date information on:

Interim guidance on the use of rapid antigen detection tests for the identification of SARS-CoV-2 infection
Overview of Testing Devices for COVID-19
Antigen Testing Devices
Point-of-care and Self-testing Devices
Test Swabs
List of Authorized Testing Devices

Health Canada Authorized

TRUSTED CANADIAN SUPPLIER

The Canadian Shield is the proud holder of a Health Canada Medical Device Establishment Licenses which permits us to manufacture and distribute medical devices in Canada.

MDEL License #: 11655 Company ID: 151799

Rapid Test - FAQs

General FAQs

The following frequently asked questions pertain to rapid tests in general, regardless of manufacturer.

Yes! The Canadian Shield holds a Medical Device Establishment License from Health Canada.

The Rapid Response COVID-19 Antigen Rapid Test Device, manufactured by BTNX Inc., is a Health Canada authorized COVID-19 testing device for Point of Care testing. The Rapid Response COVID-19 Antigen Rapid Test Device is intended for use by trained laboratory personnel or health care professionals.

For a full list of authorized testing devices, please visit the Health Canada website.

Yes, there is tax charged on rapid tests! While there is a zero-rated tax exemption on PPE products (such as face shields and face masks), there is currently no zero-rated tax exemption for rapid testing devices in Canada.

Rapid Tests are used as a serial screening tool whereby individuals test themselves 2 or 3 times a week to detect if they are an asymptomatic carrier of covid-19. These tests are most effective when you are infectious and are one more layer of peace of mind and safety. 

Rapid antigen testing devices should only be used for screening purposes. Nucleic acid-based testing, also called molecular testing or PCR, is the gold standard to diagnose active COVID-19 infection in patients with symptoms. For more information about self-testing and antigen testing devices, please visit the Health Canada website here

If the appropriate test procedure and result interpretation has been followed and the result of your rapid antigen test is positive – contact your healthcare providers. You will need to have a second swab taken within 48 hours with a regular laboratory-based PCR test or a rapid molecular test. This may occur at a designated testing site. The result from this test would confirm if you truly tested positive for COVID-19. Continue to self-isolate while waiting for the laboratory PCR test result.

The BTNX Rapid Response Rapid Test cannot be used for travel. The regulations around COVID testing for travel is highly dependent on the country you are traveling to. While rapid antigen tests may be accepted in some countries, these tests need to be performed and signed-off by a trained individual, doctor, or pharmacist. We highly recommend you inquire with your country of destination or airline to find out what type of test you need to travel.  

Compared to the regular laboratory-based PCR test, COVID-19 rapid antigen tests must be considered preliminary. The results from the antigen test must be confirmed with a regular laboratory-based PCR test. Interpretation of results in different populations varies based on specimen type collected and pre-test probability of COVID-19 in the patient being tested.

If we adjust the timeline for pre-orders online, this is for all *new* pre-orders going forward.

The Canadian Shield team is actively working to fulfill pre-orders within the stated timeline when you placed your order. If anything should change, our team will be in touch.

Currently, there are national supply chain shortages for rapid tests that have caused some delays. We appreciate your patience and we look forward to getting rapid tests into the hands of Canadians across the country very soon.

BTNX Rapid Response® FAQs

The following frequently asked questions pertain specifically to the BTNX Inc. Rapid Response COVID-19 Rapid Antigen Test.

Yes. Like all medical devices, the Rapid Response COVID-19 Rapid Antigen Testing device has an expiration date listed on the outside of the kit box as well as the Cassette testing device package. This expiration date is approximately 1 year from the manufacturing date. 

This timeline is given for informational purposes only. Always refer to expiration date on the packaging.

The BTNX nasal swabs are sterilized using ethylene oxide. This process is completely safe for the user and has been used for decades on medical equipment. The sterilization process follows ISO 11135 (Sterilization of health-care products) and ISO 10993 (Biological evaluation of medical devices). Additionally, all nasal swabs have passed testing for both toxicology and biocompatibility. 

Rapid tests should be stored in a cool, dry place. Please refer to the side of the rapid test kit packaging for the exact temperature requirements.

As the weather gets colder in Canada, we understand some customers may be concerned about the sub-zero temperatures during the shipment of Rapid Test Kits.

Transport temperatures dipping below 0°C for short durations of time will not have an adverse effect on the test, or the buffer liquid.

Recommendation:
It’s important to bring the tests to room temperature before adding the sample into the test, as low ambient temperatures when conducting the test may cause false results. We recommend letting the test kit contents sit out for 4-6 hours before use.

Impact of the Omicron variant of SARS-CoV-2 on BTNX’s Rapid Response® COVID-19 Antigen Rapid Test Device

Statement from device manufacturer:

View full statement here.

You may collect your sample using either method, however collecting an anterior nasal swab only requires you to insert the swab 0.5 inches (1-2cm) into the nostril making it a simpler method of collection and leading to less discomfort that the nasopharyngeal collection. Both the nasopharyngeal and anterior nasal swab collection methods are capable of being used for rapid antigen testing to detect the SARS-CoV-2 nucleoprotein.

Corporate &

Bulk Orders

For larger orders of rapid tests, please use the Contact Form below to contact our Sales Team for a custom quote.